Where analytical transparency meets research-grade excellence
The RADIANCE global program studied the Paradise system in three independently powered, sham-controlled, randomized clinical trials in over 500 patients with uncontrolled hypertension: RADIANCE II and RADIANCE-HTN SOLO, which studied patients with mild-moderate hypertension in an off-meds setting, and RADIANCE-HTN TRIO, which studied patients with resistant hypertension on standardized triple antihypertensive therapy
The two can occur at the same time, and a telogen effluvium can unmask a previously invisible AGA
Aguayo-Cern KA, Snchez-Muoz F, Gutierrez-Rojas RA, Acevedo-Villavicencio LN, Flores-Zarate AV, Huang F, Giacoman-Martinez A, Villafaa S, Romero-Nava R
Sluggish Metabolism Many adults describe their metabolism as broken after years of failed dieting